Home » Topics » Regulatory » Patents

Patents
RSS

Bayer Pharma identifies new N-lysine methyltransferase SMYD2 inhibitors

Oct. 31, 2016

Hawaii Biotech describes new Botulinum neurotoxin type A light chain inhibitors

Oct. 31, 2016

AbbVie discloses novel TNF-alpha modulators

Oct. 31, 2016

Plexxikon divulges FLT3 mutant inhibitors for leukemia

Oct. 28, 2016

Dana-Farber Cancer Institute patent describes CDK inhibitors

Oct. 28, 2016

Eisai reports FGFR-4 inhibitors for liver cancer

Oct. 28, 2016

Gedeon Richter patents MCH1 receptor antagonists

Oct. 28, 2016

Shanghai Huilun Life Science & Technology patents PARP-1 inhibitors

Oct. 28, 2016

Merck & Co. develops FXIa and/or plasma kallikrein inhibitors

Oct. 27, 2016

Eli Lilly describes GOAT inhibitors

Oct. 27, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...